Recombinant Micrococcus luteus Argininosuccinate synthase (argG)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the in-stock format unless you specify a format preference when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specific delivery times. Proteins are shipped with blue ice packs by default; request dry ice in advance for an extra fee.
Notes
Avoid repeated freezing and thawing. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
argG; Mlut_14340; Argininosuccinate synthase; EC 6.3.4.5; Citrulline--aspartate ligase
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-413
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Micrococcus luteus (strain ATCC 4698 / DSM 20030 / JCM 1464 / NBRC 3333 / NCIMB 9278 / NCTC 2665 / VKM Ac-2230) (Micrococcus lysodeikticus)
Target Names
argG
Target Protein Sequence
MKERIILAYS GGLDTSVAIG WIAEATGAEV VAVAVDVGQG GESLETIRQR ALDCGAVEAY VADARDEFAE QYCMPTLKAN ALYMDAYPLV SAISRPVISR HLVAAARQFG ASTVAHGCTG KGNDQVRFEV SIQTLGPDLK CIAPVRDLAL TREKAIEYAE RNDLPIVTTK KNPFSIDQNV WGRAVETGFL EDIWNGPTKD VYDYTDDPAF PPAPDVVTIA FERGVPTALD GRALSPLEII EELNRRAGAQ GVGRIDIVED RLVGIKSREI YEAPGAMALI AAHRELENVT LEREQARFKK HVDQRWTELV YDGQWYSPLK RNLDTFIDAT QEHVNGEIRL ELHGGRATVQ GRRSETGLYD FNLATYDEGD SFDQSSARGF IDIFGLSAKT ASEREQRLRG SADLQDVARL SND
Uniprot No.

Target Background

Database Links
Protein Families
Argininosuccinate synthase family, Type 1 subfamily
Subcellular Location
Cytoplasm.

Q&A

Basic Research Questions

  • What is the role of Argininosuccinate Synthase (argG) in Micrococcus luteus metabolism?

    Argininosuccinate Synthase (encoded by the argG gene) is a critical enzyme in the arginine biosynthesis pathway in Micrococcus luteus, a high GC Gram-positive bacterium belonging to the phylum Actinobacteria . The enzyme catalyzes the penultimate step in arginine biosynthesis, condensing citrulline and aspartate to form argininosuccinate, which is subsequently cleaved by argininosuccinate lyase to produce arginine.

    In M. luteus, which has one of the smallest genomes among free-living actinobacteria (with 2148-2501 coding sequences depending on strain), argG is part of the core genome and essential for cellular viability in environments lacking arginine . The enzyme's function is particularly significant given M. luteus's adaptation to diverse habitats ranging from soil to the human body, indicating its importance in the organism's metabolic versatility .

  • How does the genomic context of argG in M. luteus differ from other bacterial species?

    The argG gene in M. luteus exists within a highly compact genome with distinctive characteristics:

    • The M. luteus genome has an exceptionally high GC content (mean 72.9%, ranging from 72.3% to 73.3%), significantly higher than many other bacterial species .

    • This high GC content affects codon usage in the argG gene, potentially influencing its expression efficiency in recombinant systems.

    • The genome contains numerous insertion sequences (159-315 per genome) and genomic islands (4-15 per genome), suggesting frequent genomic exchanges that may have influenced argG evolution .

    Unlike some bacterial species where arginine biosynthesis genes are organized in operons, the genomic organization around argG in M. luteus may reflect specific regulatory adaptations to its ecological niches. These genomic differences should be considered when expressing recombinant M. luteus argG in heterologous hosts.

  • What expression systems are most effective for producing recombinant M. luteus argG?

    Based on experimental protocols for similar enzymes and argG specifically, the following expression systems are recommended:

    • E. coli-based expression: BL21(DE3) strain with pET-system vectors under T7 promoter control is effective, though codon optimization may be necessary due to M. luteus's high GC content .

    • Complementation systems: For functional studies, expressing M. luteus argG in E. coli argG deletion strains provides a clean background for assessing variant functionality .

    • Temperature-controlled expression systems: For temperature-sensitive variants, the following protocol has proven successful:

      Expression ParameterRecommended Condition
      Growth mediumTerrific Broth (TB)
      Initial growth37°C to OD 0.6
      Induction0.1 M IPTG (1% v/v)
      Post-induction16°C overnight
      Shaking220 rpm

      This low-temperature post-induction incubation promotes proper folding and increased solubility of the recombinant enzyme .

  • What purification strategy yields the highest activity for recombinant M. luteus argG?

    For optimal purification of recombinant M. luteus argG with preserved activity, the following methodological approach is recommended:

    1. Cell harvest and lysis:

      • Centrifuge cultures at 4000 rpm, 4°C, for 30 minutes

      • Resuspend in appropriate lysis buffer (e.g., 50 mM NaH₂PO₄, pH 8.0)

      • Maintain all steps at 4°C to preserve enzyme stability

    2. Chromatographic purification sequence:

      • Immobilized metal affinity chromatography (IMAC) for His-tagged proteins

      • Ion exchange chromatography as a secondary purification step

      • Size exclusion chromatography for final polishing

    3. Buffer optimization:

      • Include ATP and Mg²⁺ in purification buffers to stabilize the enzyme

      • Add reducing agents (1-5 mM DTT or β-mercaptoethanol) to prevent oxidation

      • Consider adding glycerol (10-15%) to enhance stability during storage

    This multi-step approach minimizes activity loss while achieving high purity, particularly important when working with temperature-sensitive variants .

Advanced Research Questions

  • How can temperature-sensitive variants of M. luteus argG be generated and characterized?

    Temperature-sensitive (TS) variants of M. luteus argG can be systematically generated and characterized through the following methodological pipeline:

    1. Variant Generation:

      • Error-prone PCR with controlled mutation rates (2-5 mutations per kb)

      • Site-directed mutagenesis targeting regions involved in protein stability

      • Domain-focused random mutagenesis

    2. High-throughput Screening System:

      • Expression of variants in an argG deletion strain

      • Use of fluorescent TIMER protein as a single-cell growth rate reporter

      • Flow cytometry-based enrichment to identify temperature-sensitive phenotypes

    3. Characterization Protocol:

      • Growth profiling at permissive (30°C) and non-permissive (42°C) temperatures

      • Assessment of conditional arginine auxotrophy (growth with/without arginine at different temperatures)

      • Protein expression and stability analysis at different temperatures

    In published studies, this approach successfully identified variants where 90% exhibited temperature-sensitive growth and 69% displayed conditional arginine auxotrophy (auxotrophic at 42°C but prototrophic at 30°C) . The best temperature-sensitive variants enable precise and tunable control of cellular growth in response to temperature changes.

  • What structural features of M. luteus argG contribute to temperature sensitivity in engineered variants?

    Temperature sensitivity in engineered M. luteus argG variants typically arises from structural modifications that affect protein stability and function in temperature-dependent ways:

    1. Critical Structural Regions:

      • Surface-exposed loops that become more flexible at elevated temperatures

      • Subunit interface residues that affect oligomerization stability

      • ATP and substrate binding pockets that may become distorted

    2. Common Mutation Patterns in Effective TS Variants:

      • Substitutions that introduce destabilizing interactions at elevated temperatures

      • Mutations affecting metal ion coordination essential for catalysis

      • Alterations in hydrophobic core packing that becomes critical at higher temperatures

    3. Structure-Function Correlation:

      • Catalytic residues are typically preserved in temperature-sensitive variants

      • Conformational flexibility rather than complete unfolding often accounts for temperature-dependent activity loss

    Understanding these structural principles enables rational design of argG variants with precisely tuned temperature sensitivity profiles for biotechnological applications.

  • How can recombinant M. luteus argG variants be applied for controlled citrulline production?

    Temperature-sensitive M. luteus argG variants provide a sophisticated tool for controlling citrulline production in engineered bacteria through the following approach:

    1. Strain Engineering Strategy:

      • Integration of temperature-sensitive argG variants in feedback-dysregulated E. coli strains

      • Optimization of citrulline precursor pathway to maximize flux

      • Deletion of competing pathways to enhance precursor availability

    2. Bioprocess Control Parameters:

      TemperatureGrowth ProfileCitrulline ProductionApplication
      30°CNormal growthLow productionBiomass accumulation
      34°CModerate growthModerate productionBalanced process
      37°CReduced growthHigh productionProduction phase
      42°CMinimal growthMaximal productionProduction optimization
    3. Metabolic Control Mechanism:

      • At higher temperatures, reduced ArgG activity creates a metabolic bottleneck

      • Citrulline, the substrate of ArgG, accumulates intracellularly

      • Citrulline overflow leads to extracellular accumulation

      • Fine-tuning temperature allows precise control of the bottleneck intensity

    This temperature-based approach offers significant advantages over chemical induction methods, including simplicity, cost-effectiveness, and precise temporal control of metabolic flux .

  • What enzymatic assays best characterize the activity and temperature sensitivity of recombinant M. luteus argG?

    Comprehensive enzymatic characterization of recombinant M. luteus argG requires multiple complementary assays:

    1. Primary Activity Assays:

      • AMP formation assay (coupled with adenylate kinase and pyruvate kinase/lactate dehydrogenase)

      • Direct measurement of argininosuccinate formation by HPLC or LC-MS

      • Citrulline consumption measurement using colorimetric methods

    2. Temperature-Dependent Activity Profile:

      • Activity measurements across temperatures (25-45°C)

      • Thermal stability assessment through activity retention after heat treatment

      • Determination of temperature optima and thermal inactivation kinetics

    3. Kinetic Parameter Determination:

      • Km values for citrulline, aspartate, and ATP at different temperatures

      • Temperature effects on kcat and catalytic efficiency (kcat/Km)

      • Activation energy determination via Arrhenius plots

    4. Recommended Protocol for Temperature-Sensitive Variants:

      • Initial activity measurement at permissive temperature (30°C)

      • Controlled temperature ramping with continuous activity monitoring

      • Determination of T50 (temperature at which 50% activity is lost)

      • Activity recovery assessment upon return to permissive temperature

    These methodological approaches collectively provide a comprehensive characterization of enzymatic behavior and temperature sensitivity profiles .

  • How does genetic background affect the functionality of recombinant M. luteus argG in heterologous hosts?

    The functionality of recombinant M. luteus argG in heterologous hosts is significantly influenced by genetic background factors:

    1. Codon Usage Adaptation:

      • M. luteus's high GC content (72.9%) creates a codon bias that may limit efficient translation in hosts with different codon preferences

      • Codon optimization for the expression host can significantly improve expression levels

    2. Metabolic Context Effects:

      • Availability of cofactors (ATP, Mg²⁺) in the host affects enzyme activity

      • Differences in cytoplasmic pH and ionic strength between M. luteus and heterologous hosts

      • Potential interference from host arginine biosynthesis regulation systems

    3. Genetic Modifications for Optimal Functionality:

      • Deletion of host argG for clean complementation studies

      • Co-expression of molecular chaperones to improve folding

      • Modification of regulatory elements to prevent interference with host metabolism

    4. Inter-Species Complementation Efficiency:

      Host SpeciesComplementation EfficiencyKey Considerations
      E. coliHighStandard expression host, requires codon optimization
      B. subtilisModerateBetter suited for GC-rich genes, different regulation
      S. cerevisiaeVariableRequires appropriate targeting, potential glycosylation

    Understanding these host-dependent factors is essential for successful heterologous expression and accurate characterization of M. luteus argG .

  • What approaches can resolve expression challenges for recombinant M. luteus argG?

    When encountering expression challenges with recombinant M. luteus argG, the following methodological solutions are recommended:

    1. Solubility Enhancement Strategies:

      • Fusion with solubility tags (MBP, SUMO, TrxA)

      • Co-expression with molecular chaperones (GroEL/ES, DnaK/J-GrpE)

      • Addition of osmolytes (glycerol, sorbitol) to expression media

      • Use of cell-free expression systems for difficult variants

    2. Expression Optimization Protocol:

      • Systematic temperature screening (15-37°C)

      • Inducer concentration titration (0.01-1.0 mM IPTG)

      • Media composition optimization (nitrogen sources, trace elements)

      • Temporal control of induction (early vs. mid-log phase)

    3. Advanced Folding Control Approaches:

      • Cold shock before induction to accumulate chaperones

      • Osmotic stress induction with 0.4-0.5 M NaCl or sucrose

      • Addition of folding enhancers (proline, arginine)

      • Controlled protein expression rate using weaker promoters

    4. Recommended Troubleshooting Workflow:

      • Initial small-scale expression screening with multiple conditions

      • Western blot analysis of soluble and insoluble fractions

      • Activity assays directly from cell lysates to identify functional expression

      • Scale-up of optimal conditions with further fine-tuning

    These systematic approaches can overcome the inherent challenges in expressing M. luteus proteins in heterologous hosts.

  • How can high-throughput flow cytometry methods be optimized for screening M. luteus argG variants?

    Optimizing high-throughput flow cytometry screening for M. luteus argG variants requires careful methodological considerations:

    1. Reporter System Design:

      • Implementation of the fluorescent TIMER protein as a growth rate reporter

      • Calibration of fluorescence profiles against known growth phenotypes

      • Optimization of reporter expression levels to maximize signal-to-noise ratio

    2. Critical Parameters for Successful Screening:

      ParameterOptimized SettingRationale
      Cell densityOD600 0.2-0.5Prevents aggregation during sorting
      Flow rate5,000-10,000 events/secBalances throughput and accuracy
      Gating strategyMulti-parameterSeparates growing from non-growing cells
      Sort modeHigh purityEnsures isolation of true positive variants
    3. Validation and Secondary Screening:

      • Immediate recovery in rich media at permissive temperature

      • Secondary screening in 96-well format with temperature shifts

      • Verification of temperature sensitivity through growth curve analysis

      • Confirmation of conditional arginine auxotrophy

    This optimized flow cytometry approach enables efficient screening of large variant libraries (>10⁵ variants) with high specificity for identifying temperature-sensitive ArgG variants with desired characteristics .

  • What are the key differences between wild-type and recombinant M. luteus argG in enzymatic properties?

    Wild-type and recombinant M. luteus argG display several important differences in enzymatic properties that researchers should consider:

    1. Structural Modifications and Their Effects:

      • Addition of affinity tags may alter local structure and stability

      • Expression-related modifications (N-/C-terminal extensions) can affect oligomerization

      • Potential differences in post-translational modifications between native and recombinant systems

    2. Comparative Enzymatic Properties:

      PropertyWild-type M. luteus argGRecombinant argG in E. coliSignificance
      Specific activityBaselineOften 70-90% of wild-typeExpression artifacts
      Temperature stabilityAdapted to M. luteus physiologyMay show altered stability profileHost adaptation effects
      Km valuesOptimized for native environmentMay differ due to purification effectsCatalytic efficiency differences
      OligomerizationNative quaternary structurePotential assembly differencesFunctional implications
    3. Environmental Factor Sensitivity:

      • Different pH optima between native and recombinant versions

      • Altered response to cellular ionic strength between host systems

      • Potential differences in allosteric regulation and feedback inhibition

    4. Implications for Research Applications:

      • Need for careful benchmarking against native enzyme properties

      • Consideration of host effects when interpreting enzyme characterization data

      • Potential requirement for optimized buffer conditions to mimic native environment

    Understanding these differences is crucial for accurate interpretation of experimental results and successful application of recombinant M. luteus argG in research and biotechnological applications.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.